Affect Therapeutics provides co-occurring mental health and
outpatient care in New Berlin, WI, supporting individuals and families working toward lasting recovery.
The facility provides levels of care including co-occurring mental health and outpatient and typical program lengths around 30 days.
Clients engage with evidence-based and supportive therapies such as 1-on-1 counseling,
group therapy, online therapy, relapse prevention counseling, motivational interviewing and
medication-assisted treatment.
This center serves men, women and young adults and treats co-occurring disorders, drug addiction, chronic relapse and smoking cessation.
Coverage is accepted from 24 plans such as MHN,
Medicaid, Medicare and Optum; the admissions team can confirm what your policy covers.
Aftercare options include continuing care, outpatient treatment and
intensive outpatient program.
To confirm current openings, levels of care, and accepted insurance, contact Affect Therapeutics directly or call our free, confidential helpline.
Evidence-Based Context: According to SAMHSA's National Survey on Drug Use and Health (2023), approximately 48.7 million Americans aged 12 or older had a substance use disorder in the past year. The National Institute on Drug Abuse (NIDA) emphasizes that treatment programs combining behavioral therapy with medication-assisted approaches show the highest rates of sustained recovery. Facilities like Affect Therapeutics provide structured pathways to evidence-based care.
Sources: SAMHSA NSDUH 2023, NIDA Principles of Drug Addiction Treatment (4th Ed.)